Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related THOR
BMO Capital Downgrades St. Jude Medical On 'Less Compelling' Risk/Reward
Benzinga's Top Downgrades
Thoratec (THOR) D. Keith Grossman on Q2 2015 Results - Earnings Call Transcript (Seeking Alpha)
Related LOW
BMO Upgrades Lowe's On Economic Improvement In American Southeast
Benzinga's Top Upgrades
Buying Dividend Growth Stocks Without Looking (Seeking Alpha)

Analysts at Goldman Sachs downgraded Thoratec (NASDAQ: THOR) from “buy” to “neutral.” The target price for Thoratec has been lowered from $42 to $37. Thoratec's shares closed at $32.60 on Friday.

Analysts at Oppenheimer downgraded Lowe's Companies (NYSE: LOW) from “outperform” to “perform.” The target price for Lowe's is set to $46. Lowe's shares closed at $42.67 on Friday.

Analysts at Keefe Bruyette & Woods downgraded Bank of America (NYSE: BAC) from “outperform” to “perform.” Bank of America's shares closed at $13.43 on Friday.

Jefferies downgraded Bed Bath & Beyond (NASDAQ: BBBY) from “buy” to “hold.” The target price for Bed Bath & Beyond has been lowered from $76 to $71. Bed Bath & Beyond's shares closed at $69.11 on Friday.

Latest Ratings for THOR

DateFirmActionFromTo
Jul 2015JP MorganMaintainsNeutral
Jul 2015Wells FargoDowngradesOutperformMarket Perform
Jul 2015Northland SecuritiesDowngradesOutperformMarket Perform

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BBBY + BAC)

Get Benzinga's Newsletters